Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
Updated . What changed?
SPRUCE BIOSCIENCES, INC. is a biotechnology business based in the US. SPRUCE BIOSCIENCES shares (SPRB) are listed on the NASDAQ and all prices are listed in US Dollars. SPRUCE BIOSCIENCES employs 15 staff and has a market cap (total outstanding shares value) of USD$372.1 million.
|Latest market close||USD$15.38|
|52-week range||USD$15 - USD$18.489|
|50-day moving average||USD$16.9133|
|200-day moving average||USD$16.9133|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-10-16)||15.38|
|1 month (2020-09-22)||N/A|
|3 months (2020-07-22)||N/A|
|6 months (2020-04-22)||N/A|
|1 year (2019-10-22)||N/A|
|2 years (2018-10-22)||N/A|
|3 years (2017-10-22)||N/A|
|5 years (2015-10-22)||N/A|
|Gross profit TTM||USD$0|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||USD$372.1 million|
TTM: trailing 12 months
We're not expecting SPRUCE BIOSCIENCES to pay a dividend over the next 12 months.
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy, which is in Phase IIb clinical trial for adult patients with classic congenital adrenal hyperplasia (CAH) and in Phase II clinical trial in children with classic CAH. It is also developing tildacerfont for females with polycystic ovary syndrome. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses. Spruce Biosciences, Inc. was founded in 2014 and is headquartered in Daly City, California.
Steps to owning and managing WK, with 24-hour and historical pricing before you buy.
Steps to owning and managing HCN, with 24-hour and historical pricing before you buy.
Steps to owning and managing VEL, with 24-hour and historical pricing before you buy.
Steps to owning and managing LEA, with 24-hour and historical pricing before you buy.
Steps to owning and managing LUB, with 24-hour and historical pricing before you buy.
Steps to owning and managing HCSG, with 24-hour and historical pricing before you buy.
Steps to owning and managing LAWS, with 24-hour and historical pricing before you buy.
Steps to owning and managing SWIR, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFBC, with 24-hour and historical pricing before you buy.
Steps to owning and managing CSIQ, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.